Additional file 1: of A multicenter randomized, double-blind, placebo-controlled pilot study to assess the efficacy and safety of riociguat in systemic sclerosis-associated digital ulcers

Nagaraja, Vivek; Spino, Cathie; Bush, Erica; Tsou, Pei-Suen; Domsic, Robyn T.; Lafyatis, Robert; Frech, Tracy; Gordon, Jessica K.; Steen, Virginia D.; Khanna, Dinesh

doi:10.6084/m9.figshare.9765983.v1

13075_2019_1979_MOESM1_ESM.pdf (904.91 kB)

Additional file 1: of A multicenter randomized, double-blind, placebo-controlled pilot study to assess the efficacy and safety of riociguat in systemic sclerosis-associated digital ulcers

journal contribution

posted on 2019-09-04, 04:54 authored by Vivek Nagaraja, Cathie Spino, Erica Bush, Pei-Suen Tsou, Robyn T. Domsic, Robert Lafyatis, Tracy Frech, Jessica K. Gordon, Virginia D. Steen, Dinesh Khanna

Complete inclusion/exclusion criteria. (PDF 904 kb)

Funding

Bayer Corporation

History

Usage metrics

Keywords

Systemic sclerosis Digital ulcers Riociguat Clinical trial

Licence

CC BY + CC0

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM

DC

Additional file 1: of A multicenter randomized, double-blind, placebo-controlled pilot study to assess the efficacy and safety of riociguat in systemic sclerosis-associated digital ulcers

Funding

Bayer Corporation

History

Usage metrics

Categories

Keywords

Licence

Exports